Covalon Technologies OTC Stock Top Insiders

CVALF Stock  USD 1.60  0.03  1.91%   
Covalon Technologies employs about 24 people. The company is managed by 10 executives with a total tenure of roughly 31 years, averaging almost 3.0 years of service per executive, having 2.4 employees per reported executive. Examination of Covalon Technologies' management performance can provide insight into the company performance.
Brian Pedlar  CEO
CEO and President and Director
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Covalon Technologies. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Covalon Technologies Management Team Effectiveness

The company has return on total asset (ROA) of (0.161) % which means that it has lost $0.161 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3213) %, meaning that it generated substantial loss on money invested by shareholders. Covalon Technologies' management efficiency ratios could be used to measure how well Covalon Technologies manages its routine affairs as well as how well it operates its assets and liabilities.

Covalon Technologies Workforce Comparison

Covalon Technologies is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 413. Covalon Technologies holds roughly 24.0 in number of employees claiming about 6% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.53) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.5) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.5.

Covalon Technologies Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Covalon Technologies Price Series Summation is a cross summation of Covalon Technologies price series and its benchmark/peer.

Covalon Technologies Notable Stakeholders

A Covalon Technologies stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Covalon Technologies often face trade-offs trying to please all of them. Covalon Technologies' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Covalon Technologies' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Valerio DiTizioCo-Founder and Chief Science OfficerProfile
Brian PedlarCEO and President and DirectorProfile
Simon SmithChief LtdProfile
Ron HebertVP MarketingProfile
Greg LeszczynskiVP HRProfile
Hamed AbbasianVP DevelProfile
Gerry ArambulaPres LtdProfile
Jason GorelInterim OfficerProfile
Elaine ZhangVP OperationsProfile
Mark DoolittleVP SalesProfile

About Covalon Technologies Management Performance

The success or failure of an entity such as Covalon Technologies often depends on how effective the management is. Covalon Technologies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Covalon management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Covalon management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. Covalon Tech operates under Biotechnology classification in the United States and is traded on OTC Exchange.
The data published in Covalon Technologies' official financial statements typically reflect Covalon Technologies' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Covalon Technologies' quantitative information. For example, before you start analyzing numbers published by Covalon accountants, it's essential to understand Covalon Technologies' liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.

Covalon Technologies Workforce Analysis

Traditionally, organizations such as Covalon Technologies use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Covalon Technologies within its industry.

Covalon Technologies Manpower Efficiency

Return on Covalon Technologies Manpower

Revenue Per Employee756.1K
Revenue Per Executive1.8M
Net Loss Per Employee402.6K
Net Loss Per Executive966.3K

Complementary Tools for Covalon OTC Stock analysis

When running Covalon Technologies' price analysis, check to measure Covalon Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Covalon Technologies is operating at the current time. Most of Covalon Technologies' value examination focuses on studying past and present price action to predict the probability of Covalon Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Covalon Technologies' price. Additionally, you may evaluate how the addition of Covalon Technologies to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like